Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEFLUNOMIDE Cause Pulmonary arterial hypertension? 40 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Pulmonary arterial hypertension have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 0.1% of all adverse event reports for LEFLUNOMIDE.

40
Reports of Pulmonary arterial hypertension with LEFLUNOMIDE
0.1%
of all LEFLUNOMIDE reports
8
Deaths
29
Hospitalizations

How Dangerous Is Pulmonary arterial hypertension From LEFLUNOMIDE?

Of the 40 reports, 8 (20.0%) resulted in death, 29 (72.5%) required hospitalization, and 6 (15.0%) were considered life-threatening.

Is Pulmonary arterial hypertension Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 40 reports have been filed with the FAERS database.

What Other Side Effects Does LEFLUNOMIDE Cause?

Drug ineffective (31,396) Rheumatoid arthritis (20,886) Pain (15,594) Drug intolerance (14,142) Joint swelling (13,026) Fatigue (11,959) Arthralgia (11,880) Rash (11,239) Contraindicated product administered (11,206) Abdominal discomfort (10,333)

What Other Drugs Cause Pulmonary arterial hypertension?

TREPROSTINIL (3,240) MACITENTAN (2,390) AMBRISENTAN (1,965) SELEXIPAG (1,387) EPOPROSTENOL (1,055) BOSENTAN (778) TADALAFIL (680) SILDENAFIL (487) RIOCIGUAT (436) ILOPROST (284)

Which LEFLUNOMIDE Alternatives Have Lower Pulmonary arterial hypertension Risk?

LEFLUNOMIDE vs LEMBOREXANT LEFLUNOMIDE vs LENACAPAVIR LEFLUNOMIDE vs LENALIDOMIDE LEFLUNOMIDE vs LENIOLISIB LEFLUNOMIDE vs LENOGRASTIM

Related Pages

LEFLUNOMIDE Full Profile All Pulmonary arterial hypertension Reports All Drugs Causing Pulmonary arterial hypertension LEFLUNOMIDE Demographics